Cardiovascular Systems Inc. (CSII)

43.99
1.90 4.10
NASDAQ : Health Technology
Prev Close 45.89
Open 45.88
Day Low/High 43.98 / 46.52
52 Wk Low/High 24.84 / 45.92
Volume 570.13K
Avg Volume 278.00K
Exchange NASDAQ
Shares Outstanding 34.83M
Market Cap 1.54B
EPS 0.10
P/E Ratio 735.50
Div & Yield N.A. (N.A)
Cardiovascular Systems Releasing Late-Breaking Confirm Series Data At ISET Conference

Cardiovascular Systems Releasing Late-Breaking Confirm Series Data At ISET Conference

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), will present late-breaking data from its CONFIRM study series, an oral abstract from its CALCIUM study, and conduct other educational and poster sessions at the 25 th...

Cardiovascular Systems Completes Patient Enrollment In Orbit II Coronary Trial

Cardiovascular Systems Completes Patient Enrollment In Orbit II Coronary Trial

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced it has completed enrollment in its ORBIT II clinical trial, enrolling 443 patients.

Cardiovascular Systems Featuring Training Lab At VEITH 2012

Cardiovascular Systems Featuring Training Lab At VEITH 2012

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), is offering 2012 VEITHsymposium™ attendees an opportunity to learn about the effectiveness of orbital atherectomy in treating peripheral arterial disease (PAD).

Cardiovascular Systems Reports Fiscal 2013 First-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2013 First-Quarter Financial Results

Cardiovascular Systems, Inc. (NASDAQ: CSII): Revenues rose to $23.

Cardiovascular Systems To Webcast Fiscal 2013 First-Quarter Earnings Conference Call Tuesday, Oct. 30

Cardiovascular Systems To Webcast Fiscal 2013 First-Quarter Earnings Conference Call Tuesday, Oct. 30

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a live webcast of its fiscal 2013 first-quarter conference call on Tuesday, Oct.

Leading Physicians To Unveil New Findings Regarding Arterial Calcification At TCT Conference

Leading Physicians To Unveil New Findings Regarding Arterial Calcification At TCT Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced today that new findings regarding arterial calcification will be unveiled at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) conference in Miami,...

CSI Presents Late-Breaking CONFIRM Series Data At VIVA 2012

CSI Presents Late-Breaking CONFIRM Series Data At VIVA 2012

Data presented yesterday from Cardiovascular Systems’ (CSI) (NASDAQ: CSII) CONFIRM study series demonstrate that CSI’s minimally invasive orbital atherectomy system is an effective treatment for peripheral ...

Cardiovascular Systems To Release Late-Breaking Peripheral Data At VIVA Conference And Introduce New CSIQ Medical Education Programs

Cardiovascular Systems To Release Late-Breaking Peripheral Data At VIVA Conference And Introduce New CSIQ Medical Education Programs

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will present data from its CONFIRM study series at the 10 th annual VIVA conference in Las Vegas, Oct.

Clinically Significant 12-Month Results From Cardiovascular Systems' Calcium 360° Study Published In Journal Of Endovascular Therapy

Clinically Significant 12-Month Results From Cardiovascular Systems' Calcium 360° Study Published In Journal Of Endovascular Therapy

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today announced publication of 12-month...

Cardiovascular Systems To Present At Stifel Nicolaus Healthcare Conference, September 5, 2012

Cardiovascular Systems To Present At Stifel Nicolaus Healthcare Conference, September 5, 2012

Cardiovascular Systems, Inc. (Nasdaq: CSII), a medical device company developing and commercializing innovative, interventional treatment systems for vascular disease, will present at the Stifel Nicolaus 2012 ...

Cardiovascular Systems Announces Physician Training And Educational Opportunities At AMP Chicago 2012 Symposium

Cardiovascular Systems Announces Physician Training And Educational Opportunities At AMP Chicago 2012 Symposium

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today announced a slate of training and...

Cardiovascular Systems Reports Fiscal 2012 Fourth-Quarter And Full-Year Financial Results

Cardiovascular Systems Reports Fiscal 2012 Fourth-Quarter And Full-Year Financial Results

Cardiovascular Systems, Inc. (Nasdaq: CSII): Revenue gains continue Revenues of $22.

Cardiovascular Systems To Webcast Fiscal 2012 Fourth-Quarter Earnings Conference Call Wednesday, Aug. 8

Cardiovascular Systems To Webcast Fiscal 2012 Fourth-Quarter Earnings Conference Call Wednesday, Aug. 8

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a live webcast of its fiscal 2012 fourth-quarter conference call on Wednesday, Aug.

Cardiovascular Systems Announces First Patients Treated With New Electric Orbital Atherectomy System In ORBIT II Coronary Trial

Cardiovascular Systems Announces First Patients Treated With New Electric Orbital Atherectomy System In ORBIT II Coronary Trial

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today announced that two patients at two...

Cardiovascular Systems Announces Five Abstract Presentations At Upcoming C3 Conference

Cardiovascular Systems Announces Five Abstract Presentations At Upcoming C3 Conference

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today announced that five abstracts focusing...

Cardiovascular Systems Reports Data From Compliance 360° Study Comparing Orbital Atherectomy Vs. Percutaneous Transluminal Angioplasty

Cardiovascular Systems Reports Data From Compliance 360° Study Comparing Orbital Atherectomy Vs. Percutaneous Transluminal Angioplasty

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), shared 12-month data from the COMPLIANCE 360° study of severely calcified above-the-knee lesions at the New Cardiovascular Horizons Annual Conference on Saturday,...

Cardiovascular Systems Announces Pricing Of Public Offering Of Common Stock

Cardiovascular Systems Announces Pricing Of Public Offering Of Common Stock

Cardiovascular Systems, Inc. (“CSI”) (Nasdaq: CSII), a medical device company focused on developing and commercializing innovative interventional treatment systems for vascular disease, today announced the...

Cardiovascular Systems To Webcast Fiscal 2012 Third-Quarter Earnings Conference Call Wednesday, May 2

Cardiovascular Systems To Webcast Fiscal 2012 Third-Quarter Earnings Conference Call Wednesday, May 2

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a live webcast of its fiscal 2012 third-quarter conference call on Wednesday, May 2, 2012, at 3:45 p.

Cardiovascular Systems’ Data For Treatment Of Peripheral Arterial Disease In Office-Based Lab Settings Presented At Society For Interventional Radiology Meeting

Cardiovascular Systems’ Data For Treatment Of Peripheral Arterial Disease In Office-Based Lab Settings Presented At Society For Interventional Radiology Meeting

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), today announced results from a study of patients treated for peripheral arterial disease (PAD) with CSI’s Diamondback™ Orbital Atherectomy System in a ...

Cardiovascular Systems’ 12-Month Data From COMPLIANCE 360° Study Of Above-the-Knee Peripheral Arterial Disease Presented At ACC

Cardiovascular Systems’ 12-Month Data From COMPLIANCE 360° Study Of Above-the-Knee Peripheral Arterial Disease Presented At ACC

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), today presented 12-month data from the COMPLIANCE 360° study of severely calcified above-the-knee lesions at the American College of Cardiology’s (ACC) 61 st ...

Cardiovascular Systems To Present 12-Month Data From COMPLIANCE 360° Study At ACC

Cardiovascular Systems To Present 12-Month Data From COMPLIANCE 360° Study At ACC

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), will present 12-month data from its COMPLIANCE 360° study at The American College of Cardiology’s (ACC's) 61 st Annual Scientific Session & Expo, ...

Cardiovascular Systems Reports Fiscal 2012 Second-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2012 Second-Quarter Financial Results

Cardiovascular Systems, Inc. (Nasdaq: CSII): Revenues increased 5 percent over the second quarter of fiscal 2011, and 6 percent over the first quarter of fiscal 2012 to $19.

Cardiovascular Systems To Webcast Fiscal 2012 Second-Quarter Earnings Conference Call Tuesday, February 7

Cardiovascular Systems To Webcast Fiscal 2012 Second-Quarter Earnings Conference Call Tuesday, February 7

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a live webcast of its fiscal 2012 second-quarter conference call on Tuesday, February 7, 2012, at 3:45 p.

Cardiovascular Systems’ Stealth 360° PAD System Honored As A New Technology Of The Year By LifeScience Alley

Cardiovascular Systems’ Stealth 360° PAD System Honored As A New Technology Of The Year By LifeScience Alley

Cardiovascular Systems, Inc. (CSI; Nasdaq: CSII), Stealth 360°™ PAD System has been honored as a New Technology of the Year by LifeScience Alley.

New Reimbursement Codes Introduced To Better Track Costs Of Treating Patients With Severely Calcified Lesions

New Reimbursement Codes Introduced To Better Track Costs Of Treating Patients With Severely Calcified Lesions

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) today announced new medical diagnosis and procedure codes for severely calcified coronary arteries.

Cardiovascular Systems’ Peripheral And Coronary Data From Six Studies Presented At TCT

Cardiovascular Systems’ Peripheral And Coronary Data From Six Studies Presented At TCT

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), yesterday presented six-month data from the COMPLIANCE 360° study of severely calcified above-the-knee lesions at the 23rd Annual Transcatheter Cardiovascular ...

Cardiovascular Systems To Present Peripheral And Coronary Data From Six Studies At TCT

Cardiovascular Systems To Present Peripheral And Coronary Data From Six Studies At TCT

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), will present six-month data from the COMPLIANCE 360° study of severely calcified above-the-knee lesions at the 23 rd Annual Transcatheter Cardiovascular...

Cardiovascular Systems Reports Fiscal 2012 First-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2012 First-Quarter Financial Results

Cardiovascular Systems, Inc. (Nasdaq: CSII): Financial performance improved over prior-year first quarter and aligned with pre-release: Revenues increased 3 percent...

Cardiovascular Systems To Webcast Fiscal 2012 First-Quarter Earnings Conference Call Wednesday, November 2

Cardiovascular Systems To Webcast Fiscal 2012 First-Quarter Earnings Conference Call Wednesday, November 2

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a live webcast of its fiscal 2012 first-quarter conference call on Wednesday, November 2, 2011, at 3:45 p.

Insiders Trading STZ, CSII, CWTR, VMI

Insiders Trading STZ, CSII, CWTR, VMI

The top 10 open-market insider purchases and sales filed at the SEC Thursday.

TheStreet Quant Rating: C (Hold)